Versuchen GOLD - Frei
Mark Zuckerberg is not ready to give up on the metaverse yet
Mint Chennai
|December 11, 2025
Meta's R&D cuts are not an admission of his pet project's failure
A sense of smug satisfaction wafts across the internet whenever a report indicates Mark Zuckerberg’s metaverse vision is in trouble.
So it was last week when my colleague Kurt Wagner broke thenews the Meta was planning cuts of up to 30% in the Reality Labs division that handles the experimental technology.
“Finally,” offered Henry Blodget, a man who made his name hyping doomed dotcom stocks. “Points for trying. Now on to other things.” The Wall Street Journal called it a ‘pivot’ away from a “yearslong vision.” Investors cheered. “The potential cost cuts could somewhat offset the historic spend to build out Meta’s Al infrastructure,” TD Securities analysts wrote, estimating cost savings of $5 billion to $6 billion. Meta shares closed the week up almost 4%.
But this isn't a pivot from the metaverse. It's a rebrand. Not for the first time, Meta’s CEO has reframed his ambitions to make his corporate spending more palatable to Wall Street—and it's worked.
Diese Geschichte stammt aus der December 11, 2025-Ausgabe von Mint Chennai.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Mint Chennai
Mint Chennai
Swiggy QIP: A red flag for long-term wealth creation?
Swiggy Ltd’s ₹10,000 crore qualified institutional placement (QIP) comes barely a year after its initial public offering (IPO).
2 mins
December 13, 2025
Mint Chennai
Rajasthan limits e-NAM 2.0 pilot amid snags; 1.0 to stay
The Centre restricted e-NAM 2.0 pilot to 10 mandis, including Tonk, Jodhpur and Sujangarh
3 mins
December 13, 2025
Mint Chennai
Tushar Adhav and politics of the dance floor
There's a 1983 song by English new wave band Re-Flex that keeps popping up in my mind every time I find myself on an Indian club floor.
4 mins
December 13, 2025
Mint Chennai
Ozempic debuts with a ₹2,200-a-week price tag
for chronic weight management, Novo Nordisk is positioning Ozempic as a treatment of type 2 diabetes with weight loss benefits, competing with Eli Lily’s Mounjaro that was launched in India in March.
1 mins
December 13, 2025
Mint Chennai
Bar hopping with Lounge
\"The things that make a cocktail really great are often very simple details—the frozen glass, the lemon twist—that transform two fingers of alcohol into an ice-glazed elixir,\" writes Alice Lascelles in her excellent guide to making cocktails at home, The Cocktail Edit.
1 mins
December 13, 2025
Mint Chennai
GST cuts, easing inflation drive rural demand revival
India’s rural economy expanded and recovered strongly in late 2025, with consumption, incomes and investment improving after a key tax reform and as inflation eased, a survey showed.
2 mins
December 13, 2025
Mint Chennai
New Delhi and France revise 1992 tax treaty
India and France have struck a deal to revise their 1992 treaty which will halve the tax on dividends paid by Indian units to French parents, potentially saving millions for companies with major operations in the South Asian nation, documents show.
1 min
December 13, 2025
Mint Chennai
A teen, a wok and stir-fries for school
I should count myself lucky.
3 mins
December 13, 2025
Mint Chennai
Mexico duty hikes to hit 75% of India Jan exports
Three-quarters of India’s exports to Mexico are set to face a major setback from 1 January 2026, according to a report released on Friday by Global Trade Research Initiative (GTRI), after the Mexican senate approved steep tariff increases on goods imported from countries that don’t have a free-trade agreement (FTA) with Mexico.
1 min
December 13, 2025
Mint Chennai
A modern-day throwback to 'Malgudi Days'
Sita Bhaskar's latest novel revisits writer R.K. Narayan’s legacy to explore class, caste, and community in Mysuru
4 mins
December 13, 2025
Listen
Translate
Change font size
